Vitrolife

Health Care Technology / Biotechnology

VITR.ST

SEK 180 (0.99)%

Share price

$ 2.4 bn

Market Cap

$ 2.5 bn

Enterprise Value

Carbon footprint

GHG emissions per $ 1 mln investment

0.02x the weighted average for S&P 500

FY2021

Primary Climate Goal

This company has not set a company-wide target for an absolute reduction in GHG emissions yet

GHG emissions and Carbon intensity

Vitrolife reported Total CO2e Emissions - Location-Based Scope 1 + Scope 2 for the twelve months ending 31 December 2021 at 1.3 Kt (+0.1/+8.3% y-o-y). At the sime time, carbon intensity plunged to 6.7 t (-1.9 /-22.1% y-o-y).

Vitrolife's Scope 3 emissions grew to 1.5 Kt (+0.3/+25% y-o-y). The time series has been volatile over the last few periods.

The company has not set a company-wide target for an absolute reduction in GHG emissions yet.

Date	Total CO2e emissions (location-based Scope 1 & 2) (Kt)	Scope 1	Scope 2	Scope 3	Revenue (USDm)	Carbon intensity (tons of CO2e) / (USDm)
2021Q4	1.3	0.58	0.74	1.5	196	6.7
2020Q4	1.2	0.52	0.7	1.2	141	8.6
2019Q4	1.3	0.52	0.81	1.9	159	8.4

Vitrolife

Carbon footprint

Primary Climate Goal

This company has not set a company-wide target for an absolute reduction in GHG emissions yet

GHG emissions and Carbon intensity

Vitrolife's carbon footprint

Company environmental metrics